Live from the NIH registry
Studies recruiting near Wilmington right now
Top 25 of 115 recruiting studies, sorted by proximity — each links to its official registry page
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Overweight, Obesity
Phase 3
Interventional 900 participants sought
Accellacare - Wilmington - 1917 Tradd Court — Wilmington, North Carolina (3.8 mi)
· Sponsor: Eli Lilly and Company
Odevixibat Pregnancy and Lactation Surveillance Program: A Study to Evaluate the Safety of Odevixibat During Pregnancy and/or Lactation
Pregnancy Related
N/A
Observational 20 participants sought
Virtual Research Coordination Center Odevixibat (BYLVAY) Pregnancy Surveillance Program — Wilmington, North Carolina (3.8 mi)
· Sponsor: Ipsen
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
Graves' Disease
Phase 2
Interventional 240 participants sought
Site Number - 1060 — Wilmington, North Carolina (3.8 mi)
· Sponsor: Immunovant Sciences GmbH
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
Heart Failure, Cardiorenal Syndrome
N/A
Interventional 320 participants sought
Novant Health New Hanover Regional Medical Center — Wilmington, North Carolina (3.8 mi)
· Sponsor: Procyrion
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Heart Failure
Phase 3
Interventional 4,200 participants sought
Wilmington Health — Wilmington, North Carolina (3.8 mi)
· Sponsor: Boehringer Ingelheim
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Type 2 Diabetes, Cortisol Excess
Phase 2
Interventional 1,500 participants sought
PMG Research of Wilmington, LLC — Wilmington, North Carolina (3.8 mi)
· Sponsor: Sparrow Pharmaceuticals
A Study of Ozanimod in Pregnant Women With Ulcerative Colitis and Their Offspring
Ulcerative Colitis
N/A
Observational 1,182 participants sought
PPD Virtual - PPD - US — Wilmington, North Carolina (3.8 mi)
· Sponsor: Bristol-Myers Squibb
Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response
Arthritis, Psoriatic
Phase 3
Interventional 600 participants sought
Clinical Site — Leland, North Carolina (9.6 mi)
· Sponsor: MoonLake Immunotherapeutics AG
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Heart Failure
Phase 3
Interventional 11,300 participants sought
Research Site — Wilmington, North Carolina (3.8 mi)
· Sponsor: AstraZeneca
IBD Pregnancy Registry
Inflammatory Bowel Disease (IBD)
N/A
Observational 832 participants sought
PPD — Wilmington, North Carolina (3.8 mi)
· Sponsor: CorEvitas
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
Chronic Kidney Disease
Phase 3
Interventional 7,000 participants sought
Research Site — Wilmington, North Carolina (3.8 mi)
· Sponsor: AstraZeneca
A Study of the Safety of Vonoprazan Exposure in Pregnant Women and Their Offspring
Erosive Esophagitis, Heartburn
N/A
Observational 728 participants sought
PPD — Wilmington, North Carolina (3.8 mi)
· Sponsor: Phathom Pharmaceuticals, Inc.
A Study to Assess the Safety and Effectiveness of ELAPR002f Injectable Gel in Adult Participants With Atrophic Acne Scars
Acne Scars
Phase 3
Interventional 395 participants sought
Wilmington Dermatology Center /ID# 256192 — Wilmington, North Carolina (3.8 mi)
· Sponsor: AbbVie
Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
Miscellaneous Neoplasm, Nos, Non-Neoplastic Condition, Nos
N/A
Interventional 535 participants sought
Novant Health New Hanover Regional Medical Center — Wilmington, North Carolina (3.8 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age
Influenza, Human
Phase 3
Interventional 54,000 participants sought
GSK Investigational Site — Wilmington, North Carolina (3.8 mi)
· Sponsor: GlaxoSmithKline
Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
Endometrial Carcinoma, Endometrial Clear Cell Adenocarcinoma
Phase 3
Interventional 360 participants sought
Novant Health New Hanover Regional Medical Center — Wilmington, North Carolina (3.8 mi)
· Sponsor: National Cancer Institute (NCI)
Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
Atopic Dermatitis (AD)
Phase 2
Interventional 105 participants sought
Enveda Investigative Site — Wilmington, North Carolina (3.8 mi)
· Sponsor: Enveda Therapeutics
A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin and Placebo on LDL-C in LLT-naïve Patients.
Hypercholesterolaemia
Phase 3
Interventional 600 participants sought
Research Site — Wilmington, North Carolina (3.8 mi)
· Sponsor: AstraZeneca
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne
Acne
Phase 1, Phase 2
Interventional 800 participants sought
Trial Management Associates - Wilmington - Floral Parkway- Site Number : 8400104 — Wilmington, North Carolina (3.8 mi)
· Sponsor: Sanofi Pasteur, a Sanofi Company
MOVE: Tenosynovial Giant Cell Tumor (TGCT) Real-World Participant Experience With Vimseltinib
Tenosynovial Giant Cell Tumor
N/A
Observational 100 participants sought
Synexus Clinical Research, US INC — Wilmington, North Carolina (3.8 mi)
· Sponsor: Deciphera Pharmaceuticals, LLC
Open Label Study to Investigate the Safety and Efficacy of Ponesimod in Moderate-to-Severe Chronic Plaque Psoriasis
Moderate-to-severe Chronic Plaque Psoriasis
Phase 3
Interventional 300 participants sought
Vanda Investigational Site — Wilmington, North Carolina (3.8 mi)
· Sponsor: Vanda Pharmaceuticals
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
Chronic Kidney Disease and Hypertension
Phase 3
Interventional 5,000 participants sought
Research Site — Wilmington, North Carolina (3.8 mi)
· Sponsor: AstraZeneca
Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE)
Complex Regional Pain Syndrome Type I
Phase 3
Interventional 270 participants sought
Ambros Clinical Trial Site — Wilmington, North Carolina (3.8 mi)
· Sponsor: Ambros Therapeutics, Inc.
Safety and Effectiveness Evaluation of the High-intensity Focused Ultrasound Device for Lifting Lax Submental and Neck Tissue
Skin Laxity (Submental and Neck), Facial Skin Laxity
N/A
Interventional 273 participants sought
Dermatology — Wilmington, North Carolina (3.8 mi)
· Sponsor: CLASSYS Inc.
A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
Crohn Disease
Phase 2
Interventional 60 participants sought
Innovo Research - Wilmington Gastroenterology Associates — Wilmington, North Carolina (3.8 mi)
· Sponsor: Eli Lilly and Company